Canada - English - Health Canada

aa pharma inc - perphenazine - tablet - 4mg - perphenazine 4mg - phenothiazines

Canada - English - Health Canada

aa pharma inc - perphenazine - tablet - 2mg - perphenazine 2mg - phenothiazines

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their components, or related compounds. perphenazine products are also contraindicated in patients with suspected or established subcortical brain damage, with or without hypothalamic damage, since a hyperthermic reaction with temperatures in excess of 104°f may occur in such patients, sometimes not until 14 to 16 hours after drug administration. total body ice-packing is recomme

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their components, or related compounds. perphenazine products are also contraindicated in patients with suspected or established subcortical brain damage, with or without hypothalamic damage, since a hyperthermic reaction with temperatures in excess of 104°f may occur in such patients, sometimes not until 14 to 16 hours after drug administration. total body ice-packing is recommended for such a reaction; antipyretics may also be useful.

Canada - English - Health Canada

d.c. labs limited - perphenazine - tablet - 2mg - perphenazine 2mg - phenothiazines

Canada - English - Health Canada

d.c. labs limited - perphenazine - tablet - 4mg - perphenazine 4mg - phenothiazines

Canada - English - Health Canada

pro doc limitee - perphenazine - tablet - 16mg - perphenazine 16mg - phenothiazines

Canada - English - Health Canada

pro doc limitee - perphenazine - tablet - 8mg - perphenazine 8mg - phenothiazines

Canada - English - Health Canada

pro doc limitee - perphenazine - tablet - 2mg - perphenazine 2mg - phenothiazines

Canada - English - Health Canada

pro doc limitee - perphenazine - tablet - 4mg - perphenazine 4mg - phenothiazines